Erratum to Global Adaptation to a Lipid Environment Triggers the Dormancy-Related Phenotype of Mycobacterium tuberculosis (mBio, (2014) 5(3),10.1128/mBio.01125-14);Global adaptation to a lipid environment triggers the dormancy- related phenotype of mycobacterium tuberculosis

mBio

Volumn 5, Issue 3, 2014, Pages

  Rodríguez, Juan G ^a   Hernández, Adriana C ^a   Helguera Repetto, Cecilia ^b   Ayala, Diana Aguilar ^b   Guadarrama Medina, Rosalina ^b   Anzóla, Juan M ^a   Bustos, Jose R ^a   Zambrano, María M ^a   González y Merchand, Jorge ^b   García, María J ^c   Portillo, Patricia Del ^a  

^a Genomics and Evolution of Communities of Environmental Microorganisms   (Colombia)

^b INSTITUTO POLITÉCNICO NACIONAL   (Mexico)

^c UNIVERSIDAD AUTÓNOMA DE MADRID   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

AMIKACIN; CARBON; FATTY ACID DERIVATIVE; GLYOXYLIC ACID; LONG CHAIN FATTY ACID; METRONIDAZOLE; MOXIFLOXACIN; RIFAMPICIN; TRANSCRIPTOME; TRANSFER RNA; FATTY ACID;

ADAPTATION; ANTIBIOTIC SENSITIVITY; ARTICLE; BACTERIAL GENE; BACTERIAL GROWTH; BIOLOGICAL MODEL; CARBON SOURCE; CONTROLLED STUDY; DORMANCY; DOSR GENE; DRUG ACTIVITY; GENE OVEREXPRESSION; GENETIC REGULATION; GROWTH RATE; IN VITRO STUDY; LIPID STORAGE; METABOLIC STRESS; MICROBIAL ACTIVITY; MYCOBACTERIUM TUBERCULOSIS; NONHUMAN; NUCLEOTIDE SEQUENCE; PHENOTYPE; PRIORITY JOURNAL; REGULATOR GENE; UPREGULATION; WHIB3 GENE; ENERGY METABOLISM; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION; GENOTYPE ENVIRONMENT INTERACTION; LIPID METABOLISM; METABOLISM; PHYSIOLOGY;

ADAPTATION, BIOLOGICAL; CARBON; ENERGY METABOLISM; FATTY ACIDS; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION, BACTERIAL; GENE-ENVIRONMENT INTERACTION; LIPID METABOLISM; MODELS, BIOLOGICAL; MYCOBACTERIUM TUBERCULOSIS; PHENOTYPE;

EID: 84904015652     PISSN: 21612129     EISSN: 21507511     Source Type: Journal    
DOI: 10.1128/mBio.02373-14     Document Type: Erratum

References (59)

1. Dye C, Scheele S, Dolin P, Pathania V, Raviglione MC. 1999. Consensus statement. Global burden of tuberculosis: estimated incidence, prevalence, and mortality by country. WHO Global Surveillance and Monitoring Project. JAMA 282: 677-686.
2. Gengenbacher M, Kaufmann SH. 2012. Mycobacterium tuberculosis: success through dormancy. FEMS Microbiol. Rev. 36: 514-532. http://dx. doi. org/10. 1111/j. 1574-6976. 2012. 00331. x.
3. Gonzalo-Asensio J, Mostowy S, Harders-Westerveen J, Huygen K, Hernández-Pando R, Thole J, Behr M, Gicquel B, Martín C. 2008. PhoP: a missing piece in the intricate puzzle of Mycobacterium tuberculosis virulence. PLoS One 3: e3496. http://dx. doi. org/10. 1371/journal. pone. 0003496.
4. Kendall SL, Withers M, Soffair CN, Moreland NJ, Gurcha S, Sidders B, Frita R, Ten Bokum A, Besra GS, Lott JS, Stoker NG. 2007. A highly conserved transcriptional repressor controls a large regulon involved in lipid degradation in Mycobacterium smegmatis and Mycobacterium tuberculosis. Mol. Microbiol. 65: 684-699. http://dx. doi. org/10. 1111/j. 1365-2958. 2007. 05827. x.
5. Voskuil MI, Visconti KC, Schoolnik GK. 2004. Mycobacterium tuberculosis gene expression during adaptation to stationary phase and lowoxygen dormancy. Tuberculosis (Edinb) 84: 218-227. http://dx. doi. org/10. 1016/j. tube. 2004. 02. 003.
6. Galagan JE, Minch K, Peterson M, Lyubetskaya A, Azizi E, Sweet L, Gomes A, Rustad T, Dolganov G, Glotova I, Abeel T, Mahwinney C, Kennedy AD, Allard R, Brabant W, Krueger A, Jaini S, Honda B, Yu WH, Hickey MJ, Zucker J, Garay C, Weiner B, Sisk P, Stolte C, Winkler JK, Van de Peer Y, Iazzetti P, Camacho D, Dreyfuss J, Liu Y, Dorhoi A, Mollenkopf HJ, Drogaris P, Lamontagne J, Zhou Y, Piquenot J, Park ST, Raman S, Kaufmann SH, Mohney RP, Chelsky D, Moody DB, Sherman DR, Schoolnik GK. 2013. The Mycobacterium tuberculosis regulatory network and hypoxia. Nature 499: 178-183. http://dx. doi. org/10. 1038/nature12337.
7. Arnvig KB, Comas I, Thomson NR, Houghton J, Boshoff HI, Croucher NJ, Rose G, Perkins TT, Parkhill J, Dougan G, Young DB. 2011. Sequence-based analysis uncovers an abundance of non-coding RNA in the total transcriptome of Mycobacterium tuberculosis. PLoS Pathog. 7: e1002342. http://dx. doi. org/10. 1371/journal. ppat. 1002342.
8. Miotto P, Forti F, Ambrosi A, Pellin D, Veiga DF, Balazsi G, Gennaro ML, Di Serio C, Ghisotti D, Cirillo DM. 2012. Genome-wide discovery of small RNAs in Mycobacterium tuberculosis. PLoS One 7: e51950. http://dx. doi. org/10. 1371/journal. pone. 0051950.
9. Peyron P, Vaubourgeix J, Poquet Y, Levillain F, Botanch C, Bardou F, Daffé M, Emile JF, Marchou B, Cardona PJ, de Chastellier C, Altare F. 2008. Foamy macrophages from tuberculous patients' granulomas constitute a nutrient-rich reservoir for M. tuberculosis persistence. PLoS Pathog. 4: e1000204. http://dx. doi. org/10. 1371/journal. ppat. 1000204.
10. Daniel J, Maamar H, Deb C, Sirakova TD, Kolattukudy PE. 2011. Mycobacterium tuberculosis uses host triacylglycerol to accumulate lipid droplets and acquires a dormancy-like phenotype in lipid-loaded macrophages. PLoS Pathog. 7: e1002093. http://dx. doi. org/10. 1371/journal. ppat. 1002093.
11. Gill WP, Harik NS, Whiddon MR, Liao RP, Mittler JE, Sherman DR. 2009. A replication clock for Mycobacterium tuberculosis. Nat. Med. 15: 211-214. http://dx. doi. org/10. 1038/nm. 1915.
12. Cubero N, Esteban J, Palenque E, Rosell A, Garcia MJ. 2013. Evaluation of the detection of Mycobacterium tuberculosis with metabolic activity in culture-negative human clinical samples. Clin. Microbiol. Infect. 19: 273-278. http://dx. doi. org/10. 1111/j. 1469-0691. 2012. 03779. x.
13. Muñoz-Elías EJ, McKinney JD. 2005. Mycobacterium tuberculosis isocitrate lyases 1 and 2 are jointly required for in vivo growth and virulence. Nat. Med. 11: 638-644. http://dx. doi. org/10. 1038/nm1252.
14. Ouellet H, Johnston JB, de Montellano PR. 2011. Cholesterol catabolism as a therapeutic target in Mycobacterium tuberculosis. Trends Microbiol. 19: 530-539. http://dx. doi. org/10. 1016/j. tim. 2011. 07. 009.
15. Schnappinger D, Ehrt S, Voskuil MI, Liu Y, Mangan JA, Monahan IM, Dolganov G, Efron B, Butcher PD, Nathan C, Schoolnik GK. 2003. Transcriptional adaptation of Mycobacterium tuberculosis within macrophages: insights into the phagosomal environment. J. Exp. Med. 198: 693-704. http://dx. doi. org/10. 1084/jem. 20030846.
16. Betts JC, Lukey PT, Robb LC, McAdam RA, Duncan K. 2002. Evaluation of a nutrient starvation model of Mycobacterium tuberculosis persistence by gene and protein expression profiling. Mol. Microbiol. 43: 717-731. http://dx. doi. org/10. 1046/j. 1365-2958. 2002. 02779. x.
17. Deb C, Lee CM, Dubey VS, Daniel J, Abomoelak B, Sirakova TD, Pawar S, Rogers L, Kolattukudy PE. 2009. A novel in vitro multiple-stress dormancy model for Mycobacterium tuberculosis generates a lipid-loaded, drug-tolerant, dormant pathogen. PLoS One 4: e6077. http://dx. doi. org/10. 1371/journal. pone. 0006077.
18. Voskuil MI, Schnappinger D, Visconti KC, Harrell MI, Dolganov GM, Sherman DR, Schoolnik GK. 2003. Inhibition of respiration by nitric oxide induces a Mycobacterium tuberculosis dormancy program. J. Exp. Med. 198: 705-713. http://dx. doi. org/10. 1084/jem. 20030205.
19. Lehninger A, Nelson D, Cox M. 2008. Lehninger principles of biochemistry, 5th ed. W. H. Freeman, New York, NY.
20. Jackson SK, Stark JM, Taylor S, Harwood JL. 1989. Changes in phospholipid fatty acid composition and triacylglycerol content in mouse tissues after infection with bacille Calmette-Guérin. Br. J. Exp. Pathol. 70: 435-441.
21. Lee W, VanderVen BC, Fahey RJ, Russell DG. 2013. Intracellular Mycobacterium tuberculosis exploits host-derived fatty acids to limit metabolic stress. J. Biol. Chem. 288: 6788-6800. http://dx. doi. org/10. 1074/jbc. M112. 445056.
22. Wang Z, Gerstein M, Snyder M. 2009. RNA-Seq: a revolutionary tool for transcriptomics. Nat. Rev. Genet. 10: 57-63. http://dx. doi. org/10. 1038/nrg2484.
23. Ehrt S, Schnappinger D. 2007. Mycobacterium tuberculosis virulence: lipids inside and out. Nat. Med. 13: 284-285. http://dx. doi. org/10. 1038/nm0307-284.
24. Huber W, von Heydebreck A, Sueltmann H, Poustka A, Vingron M. 2003. Parameter estimation for the calibration and variance stabilization of microarray data. Stat. Appl. Genet. Mol. Biol. 2: Article3. http://dx. doi. org/10. 2202/1544-6115. 1008.
25. Cole ST, Brosch R, Parkhill J, Garnier T, Churcher C, Harris D, Gordon SV, Eiglmeier K, Gas S, Barry CE III, Tekaia F, Badcock K, Basham D, Brown D, Chillingworth T, Connor R, Davies R, Devlin K, Feltwell T, Gentles S, Hamlin N, Holroyd S, Hornsby T, Jagels K, Krogh A, McLean J, Moule S, Murphy L, Oliver K, Osborne J, Quail MA, Rajandream MA, Rogers J, Rutter S, Seeger K, Skelton J, Squares R, Squares S, Sulston JE, Taylor K, Whitehead S, Barrell BG. 1998. Deciphering the biology of Mycobacterium tuberculosis from the complete genome sequence. Nature 393: 537-544. http://dx. doi. org/10. 1038/31159.
26. Roy H, Ibba M. 2008. RNA-dependent lipid remodeling by bacterial multiple peptide resistance factors. Proc. Natl. Acad. Sci. U. S. A. 105: 4667-4672. http://dx. doi. org/10. 1073/pnas. 0800006105.
27. Maloney E, Stankowska D, Zhang J, Fol M, Cheng QJ, Lun S, Bishai WR, Rajagopalan M, Chatterjee D, Madiraju MV. 2009. The twodomain LysX protein of Mycobacterium tuberculosis is required for production of lysinylated phosphatidylglycerol and resistance to cationic antimicrobial peptides. 5: e1000534. http://dx. doi. org/10. 1371/journal. ppat. 1000534. PLoS Pathog.
28. Francklyn CS, Minajigi A. 2010. tRNA as an active chemical scaffold for diverse chemical transformations. FEBS Lett. 584: 366-375. http://dx. doi. org/10. 1016/j. febslet. 2009. 11. 045.
29. Ernst CM, Peschel A. 2011. Broad-spectrum antimicrobial peptide resistance by MprF-mediated aminoacylation and flipping of phospholipids. Mol. Microbiol. 80: 290-299. http://dx. doi. org/10. 1111/j. 1365-2958. 2011. 07576. x.
30. Flores J, Espitia C. 2003. Differential expression of PE and PE_PGRS genes in Mycobacterium tuberculosis strains. Gene 318: 75-81. http://dx. doi. org/10. 1016/S0378-1119(03)00751-0.
31. McEvoy CR, Cloete R, Müller B, Schürch AC, van Helden PD, Gagneux S, Warren RM, Gey van Pittius NC. 2012. Comparative analysis of Mycobacterium tuberculosis pe and ppe genes reveals high sequence variation and an apparent absence of selective constraints. PLoS One 7: e30593. http://dx. doi. org/10. 1371/journal. pone. 0030593.
32. Marrero J, Rhee KY, Schnappinger D, Pethe K, Ehrt S. 2010. Gluconeogenic carbon flow of tricarboxylic acid cycle intermediates is critical for Mycobacterium tuberculosis to establish and maintain infection. Proc. Natl. Acad. Sci. U. S. A. 107: 9819-9824. http://dx. doi. org/10. 1073/pnas. 1000715107.
33. Rhee KY, Carvalho LP, Bryk R, Ehrt S, Marrero J, Park SW, Schnappinger D, Venugopal A, Nathan C. 2011. Central carbon metabolism in Mycobacterium tuberculosis: an unexpected frontier. Trends Microbiol. 19: 307-314. http://dx. doi. org/10. 1016/j. tim. 2011. 03. 008.
34. Singh A, Crossman DK, Mai D, Guidry L, Voskuil MI, Renfrow MB, Steyn AJ. 2009. Mycobacterium tuberculosis WhiB3 maintains redox homeostasis by regulating virulence lipid anabolism to modulate macrophage response. PLoS Pathog. 5: e1000545. http://dx. doi. org/10. 1371/journal. ppat. 1000545.
35. Honaker RW, Dhiman RK, Narayanasamy P, Crick DC, Voskuil MI. 2010. DosS Responds to a Reduced electron transport system to induce the Mycobacterium tuberculosis DosR regulon. J. Bacteriol. 192: 6447-6455. http://dx. doi. org/10. 1128/JB. 00978-10.
36. Mukhopadhyay S, Nair S, Ghosh S. 2012. Pathogenesis in tuberculosis: transcriptomic approaches to unraveling virulence mechanisms and finding new drug targets. FEMS Microbiol. Rev. 36: 463-485. http://dx. doi. org/10. 1111/j. 1574-6976. 2011. 00302. x.
37. Farhana A, Guidry L, Srivastava A, Singh A, Hondalus MK, Steyn AJ. 2010. Reductive stress in microbes: implications for understanding Mycobacterium tuberculosis disease and persistence. Adv. Microb. Physiol. 57: 43-117. http://dx. doi. org/10. 1016/B978-0-12-381045-8. 00002-3.
38. Garton NJ, Waddell SJ, Sherratt AL, Lee SM, Smith RJ, Senner C, Hinds J, Rajakumar K, Adegbola RA, Besra GS, Butcher PD, Barer MR. 2008. Cytological and transcript analyses reveal fat and lazy persister-like bacilli in tuberculous sputum. PLoS Med. 5: e75. http://dx. doi. org/10. 1371/journal. pmed. 0050075.
39. Piccaro G, Giannoni F, Filippini P, Mustazzolu A, Fattorini L. 2013. Activities of drug combinations against Mycobacterium tuberculosis grown in aerobic and hypoxic acidic conditions. Antimicrob. Agents Chemother. 57: 1428-1433. http://dx. doi. org/10. 1128/AAC. 02154-12.
40. Murphy DJ, Brown JR. 2007. Identification of gene targets against dormant phase Mycobacterium tuberculosis infections. BMC Infect. Dis. 7: 84. http://dx. doi. org/10. 1186/1471-2334-7-84.
41. Wallis RS, Patil S, Cheon SH, Edmonds K, Phillips M, Perkins MD, Joloba M, Namale A, Johnson JL, Teixeira L, Dietze R, Siddiqi S, Mugerwa RD, Eisenach K, Ellner JJ. 1999. Drug tolerance in Mycobacterium tuberculosis. Antimicrob. Agents Chemother. 43: 2600-2606.
42. Kumar A, Majid M, Kunisch R, Rani PS, Qureshi IA, Lewin A, Hasnain SE, Ahmed N. 2012. Mycobacterium tuberculosis DosR regulon gene Rv0079 encodes a putative, "dormancy associated translation inhibitor (DATIN). " PLoS One 7: e38709. http://dx. doi. org/10. 1371/journal. pone. 0038709.
43. Sultana R, Tanneeru K, Guruprasad L. 2011. The PE-PPE domain in mycobacterium reveals a serine-/-hydrolase fold and function: an insilico analysis. PLoS One 6: e16745. http://dx. doi. org/10. 1371/journal. pone. 0016745.
44. Leblanc C, Prudhomme T, Tabouret G, Ray A, Burbaud S, Cabantous S, Mourey L, Guilhot C, Chalut C. 2012. 4=-Phosphopantetheinyl transferase PptT, a new drug target required for Mycobacterium tuberculosis growth and persistence in vivo. PLoS Pathog. 8: e1003097. http://dx. doi. org/10. 1371/journal. ppat. 1003097.
45. Rodriguez JG, Burbano CS, Nuñez C, González CE, Zambrano MM, García MJ, Del Portillo P. 2008. Rv3134c/devR/devS operon of Mycobacterium bovis BCG is differentially transcribed under "in vitro" stress conditions. Tuberculosis (Edinb) 88: 273-282. http://dx. doi. org/10. 1016/j. tube. 2007. 11. 011.
46. Uplekar S, Rougemont J, Cole ST, Sala C. 2013. High-resolution transcriptome and genome-wide dynamics of RNA polymerase and NusA in Mycobacterium tuberculosis. Nucleic Acids Res. 41: 961-977. http://dx. doi. org/10. 1093/nar/gks1260.
47. Thompson WA, Newberg LA, Conlan S, McCue LA, Lawrence CE. 2007. The Gibbs centroid sampler. Nucleic Acids Res. 35: W232-W237. http://dx. doi. org/10. 1093/nar/gkm265.
48. Reyes A, Sandoval A, Cubillos-Ruiz A, Varley KE, Hernández-Neuta I, Samper S, Martín C, García MJ, Ritacco V, López L, Robledo J, Zambrano MM, Mitra RD, Del Portillo P. 2012. IS-seq: a novel high throughput survey of in vivo IS6110 transposition in multiple Mycobacterium tuberculosis genomes. BMC Genomics 13: 249. http://dx. doi. org/10. 1186/1471-2164-13-249.
49. Griffin JE, Gawronski JD, Dejesus MA, Ioerger TR, Akerley BJ, Sassetti CM. 2011. High-resolution phenotypic profiling defines genes essential for mycobacterial growth and cholesterol catabolism. PLoS Pathog. 7: e1002251. http://dx. doi. org/10. 1371/journal. ppat. 1002251.
50. Barry CE, Boshoff HI, Dartois V, Dick T, Ehrt S, Flynn J, Schnappinger D, Wilkinson RJ, Young D. 2009. The spectrum of latent tuberculosis: rethinking the biology and intervention strategies. Nat. Rev. Microbiol. 7: 845-855. http://dx. doi. org/10. 1038/nrmicro2236.
51. Gonzalez-y-Merchand JA, Garcia MJ, Gonzalez-Rico S, Colston MJ, Cox RA. 1997. Strategies used by pathogenic and nonpathogenic mycobacteria to synthesize rRNA. J. Bacteriol. 179: 6949-6958.
52. Waldbauer JR, Rodrigue S, Coleman ML, Chisholm SW. 2012. Transcriptome and proteome dynamics of a light-dark synchronized bacterial cell cycle. PLoS One 7: e43432. http://dx. doi. org/10. 1371/journal. pone. 0043432.
53. Langmead B, Trapnell C, Pop M, Salzberg SL. 2009. Ultrafast and memory-efficient alignment of short DNA sequences to the human genome. Genome Biol. 10: R25. http://dx. doi. org/10. 1186/gb-2009-10-3-r25.
54. Rutherford K, Parkhill J, Crook J, Horsnell T, Rice P, Rajandream MA, Barrell B. 2000. Artemis: sequence visualization and annotation. Bioinformatics 16: 944-945. http://dx. doi. org/10. 1093/bioinformatics/16. 10. 944.
55. Gonzalez-Y-Merchand JA, Zaragoza-Contreras R, Guadarrama-Medina R, Helguera-Repetto AC, Rivera-Gutierrez S, Cerna-Cortes JF, Santos-Argumedo L, Cox RA. 2012. Evaluation of the cell growth of mycobacteria using Mycobacterium smegmatis mc2 155 as a representative species. J. Microbiol. 50: 419-425. http://dx. doi. org/10. 1007/s12275-012-1556-0.
56. Rivals I, Personnaz L, Taing L, Potier MC. 2007. Enrichment or depletion of a GO category within a class of genes: which test? Bioinformatics 23: 401-407. http://dx. doi. org/10. 1093/bioinformatics/btl633.
57. Carlson J, Heckerman D, Shani G. 2009. Estimating false discovery rates for contingency tables. Microsoft Research, Redmond, WA. http://research. microsoft. com/pubs/80571/fdr%20for%20contingency%20 tables. pdf.
58. Wang L, Feng Z, Wang X, Zhang X. 2010. DEGseq: an R package for identifying differentially expressed genes from RNA-seq data. Bioinformatics 26: 136-138. http://dx. doi. org/10. 1093/bioinformatics/btp612.
59. Edgar R, Domrachev M, Lash AE. 2002. Gene Expression Omnibus: NCBI gene expression and hybridization array data repository. Nucleic Acids Res. 30: 207-210. http://dx. doi. org/10. 1093/nar/30. 1. 207.